First COVID-19 breath test authorized for use in U.S.
The device takes three minutes to return results and has been found to be over 90 percent accurate in detecting positive COVID-19 cases.
The device takes three minutes to return results and has been found to be over 90 percent accurate in detecting positive COVID-19 cases.
A new Yale study shows that one in three patients with a severe skin disease were able to regrow hair after being treated with a common arthritis drug.
The new study led by researchers from Imperial College London found that people also reported a reduction in their depression symptoms alongside these brain changes.
Scientists from SomaLogic in Boulder, CO have developed a blood test that can predict whether someone is at high risk of a heart attack, stroke, heart failure within the next four years.
Locked-in syndrome is a rare condition that makes it impossible for the patient to move or speak, but are still conscious and can see, hear, and smell.
The trial is expected to run until mid-2023. By that point it is hoped one of the three formulations will have demonstrated robust immune responses and Phase 2 trials can commence.
The Crib A’Glow can now be found in 500 hospitals across Nigeria and neighboring Ghana. It has already been used on 300,000 babies.
Clinical trials at Rice University are expected to begin in the next few months, after results on mice were described as “very exciting.”
The government is no longer granting environmental permits for open-pit mining projects, the Ministry of Energy, Natural Resources, Environment and Mines. It also plans to shut down open-pit mines already in operation.
In a study of 20,000 pregnant women, baby death rates in ethnic groups were three times lower than normal when the tool was used.